Table 2.
Temporal trends in the age-standardised incidence of BTC by geographic region of interest [12, 33, 36–38, 43–45]
| Site | Study | Data year(s) | Incidence trends (APC in ASR/100,000, %) | ||
|---|---|---|---|---|---|
| Asia | Europe | US | |||
| BTC | Koshiol 2022 [12] | 2001–2015 | +1.76 | ||
| Rahman 2022 [36] | 1993–2019 | −0.13 (SE) | |||
| iCCA | Florio 2020 [33] | 1993–2012 | −1.0 (TH); +11.1 (CN) | −1.0 (DK); +7.5 (DE) | +2.0 |
| Rahman 2022 [36] | 1993–2019 | +1.7 (SE) | |||
| Koshiol 2022 [12] | 2001–2015 | +6.7 | |||
| Javle 2022 [43] | 2013–2017 | +9.3 | |||
| Hong 2022 [44] | 2008–2019 | −4.38 (KR) | |||
| eCCA | Florio 2020 [33] | 1993–2012 | +1.4 (JP); +8.8 (TH) | +2.0 (FR); +4.0 (IT) | +2.4 |
| Koshiol 2022 [12] | 2001–2015 | +0.72 | |||
| Javle 2022 [43] | 2013–2017 | −1.97 | |||
| Kang 2022 [38] | 1999–2019 | +0.76 (KR) | |||
| GBC | SEER-22 [45] | 2015–2019 | −0.1 | ||
| Koshiol 2022 [12] | 2001–2015 | −0.25 | |||
| Rahman 2022 [36] | 1993–2019 | −2.82 (SE) | |||
| Kang 2022 [38] | 1999–2019 | −0.87 (KR) | |||
| AC | Koshiol 2022 [12] | 2001–2015 |
Male: −0.14 Female: −0.08 |
||
| Ghiringhelli 2023 [37] | 2015–2019 |
Male: −14.6 (FR) Female: −16.6 (FR) |
|||
AC ampullary cancer, APC annual percentage change, ASR age-standardised rate, BTC biliary tract cancer, CN China, DE Germany, DK Denmark, eCCA extrahepatic cholangiocarcinoma, FR France, GBC gallbladder cancer, iCCA intrahepatic cholangiocarcinoma, IT Italy, JP Japan, KR South Korea, SE Sweden, TH Thailand, US United States